抗菌药物治疗儿童化脓性关节炎的药物经济学研究  

Pharmacoeconomic Research of Antibacterial Drug Therapy in Child Suppurative Arthritis

作　　者：丁翔宇[1] 张古英[1] 冯卿[2] 李瑞宏[1] 支丽娟[1] 

机构地区：[1]河北省儿童医院,河北石家庄050031 [2]石家庄医学高等专科学校,河北石家庄050061

出　　处：《中国药业》2014年第22期69-70,共2页China Pharmaceuticals

基　　金：河北省卫生厅医学科学研究课题计划;项目编号:20130393

摘　　要：目的探讨儿童化脓性关节炎的最佳药物治疗方案,以最低成本获得最佳疗效。方法采用药物经济学方法分析医院2012年至2013年收治的65份儿童化脓性关节炎的病历,根据给药方案分成4组,进行成本-效果分析。结果 4种治疗方案的有效率比较,差异无统计学意义(P>0.05),头孢替唑钠治疗方案成本最小,成本-效果比值最低。结论头孢替唑钠是治疗儿童化脓性关节炎的最佳方案。Objective To research the optimal medication therapeutic scheme for obtaining the best effect by the lowest cost in treating child suppurative arthritis. Methods The pharmacoeconomic method was adopted to analyze the medical records in 65 cases of child suppurative arthritis treated in our hospital from 2012 to 2013. The cases were divided into 4 groups according to the medication schemes and performed the cost-effect analysis. Results There was no statistically significant difference in the effective rate among 4 kinds of treatment scheme （ P 〉 0. 05 ） ,the cost of the ceftezole sodium treatment scheme was minimal,the cost-effectiveness ratio was also lowest. Conclusion The ceftezole sodium medication scheme is the best treatment scheme for treating child suppurative arthritis.

关 键 词：儿童 抗菌药物 化脓性关节炎 药物经济学 

分 类 号：F407.7[经济管理—产业经济] R969.3[医药卫生—药理学]